跳至主要内容
临床试验/JPRN-UMIN000020636
JPRN-UMIN000020636已完成未知

Risk stratification of cardiogenic cerebral embolism using serological parameters, and efficacy and safety of pharmacological and non-pharmacological treatment: prospective study - Prospective study of risk stratification of cardiogenic cerebral embolism using serological parameters

ational Cerebral and Cardiovascular Center Department of Cardiovascular Medicine Division of Arrhythmia and Electrophysiology0 个研究点目标入组 400 人开始时间: 2016年1月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) patients who could not receive anticoagulation (2) patients with severely impaired renal function (3) patients with absolute indication for warfarin (4) patients who are considered as ineligible for this study by attending physician

研究者

发起方
ational Cerebral and Cardiovascular Center Department of Cardiovascular Medicine Division of Arrhythmia and Electrophysiology

相似试验

Risk stratification of cardiogenic cerebral embolism... | 临床试验